In developing countries, cervical cancer kills more women than any other cancer. Over 80% of women newly diagnosed with cervical cancer live in these countries. Most have never been screened; many are diagnosed too late for recovery.
Thanks to HPV self-testing, cervical cancer is one of the easiest cancers to detect, treat, and cure when caught early. If every woman were screened just once in her lifetime, global cervical cancer rates would drop by 30%; screened twice, rates drop by 60%1.
Women in developing nations are no more susceptible to the disease than their sisters in the first world. They simply do not have access to screening and treatment.
It’s time we stand up and do something.
Women’s health is now in their hands.
About HPV Self-Testing ↓
HPV self-testing has the potential to reach more women in rural areas where access to health facilities is limited.
Having the opportunity to be tested without having a pelvic exam has proven to be far more acceptable to women. Self-testing gives women privacy, autonomy, and dignity.
HPV testing provides the highest-quality screening for cervical cancer available and we are introducing it to regions of the world with the greatest need.
The Grounds for Health model leverages resources and expertise from partners across multiple sectors and continents, engaging with local and national governments, private industry partners, and community groups like coffee cooperatives—all of whom share our commitment to keeping women healthy. With our sights always on increasing the number of women treated, we build local capacity to ensure that the systems and resources needed to sustain scale and quality of services remain in place over the long term.
We are continuously exploring possibilities for new program sites, new technology, and new approaches. There is an overwhelming need for cervical cancer services all over the developing world, and Grounds for Health is meeting this challenge head-on with quality, scalable and sustainable solutions.
1 Goldie S.J, Gaffikin L, Goldhaber-Fiebert J.D, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med. 2005, 353(20):2158–2168.